Cytogenetic Testing: 4 Key Methods Dermatologists Use
Understanding chromosome analysis and genetic testing for skin disease diagnosis.
What Is Cytogenetic Testing?
Cytogenetic testing is a laboratory technique that examines the structure and number of chromosomes in cells to diagnose genetic disorders, malignancies, and inherited conditions. The field of cytogenetics focuses on the study of chromosomes and chromosome-related abnormalities, providing dermatologists and other physicians with critical diagnostic information. This specialized testing has become an essential component of modern dermatological practice, particularly for identifying genodermatoses—inherited skin disorders that encompass over 560 distinct skin conditions.
Cytogenetic analysis, also known as chromosome analysis or karyotyping, enables clinicians to visualize and evaluate the complete set of chromosomes within a cell. Unlike molecular techniques that focus on specific genes, cytogenetic testing provides a broader overview of chromosomal integrity, making it particularly valuable for detecting large-scale genetic abnormalities including whole chromosome losses or gains, translocations, and deletions.
Types of Cytogenetic Testing Methods
Several established cytogenetic techniques are routinely employed in dermatological practice, each with specific applications and advantages:
Karyotyping
Karyotyping is the traditional and most widely recognized cytogenetic technique, representing the foundational method for chromosome analysis. This procedure involves culturing cells, arresting them during metaphase, staining the chromosomes with special dyes, and then photographing and arranging them to create a visual representation of the complete chromosome complement. Karyotyping can identify numerical chromosome abnormalities (such as trisomy or monosomy) and large structural rearrangements, though it has a diagnostic yield of only 5-15% for certain genetic conditions.
Fluorescence In Situ Hybridization (FISH)
FISH is a molecular cytogenetic technique that uses fluorescently labeled DNA probes to detect specific chromosomal sequences and abnormalities. This method is particularly valuable for identifying targeted chromosomal regions and is more sensitive than traditional karyotyping for detecting specific abnormalities. FISH allows for the visualization of specific genes or chromosomal regions and can detect smaller chromosomal changes than conventional karyotyping.
Chromosomal Microarray Analysis
Chromosomal microarray (also called comparative genomic hybridization or CGH) is a modern technique that detects copy number variations (CNVs) with greater sensitivity and resolution than traditional karyotyping. This method can identify deletions and duplications as small as 1 kilobase and has a diagnostic yield of 15-20%. Microarray technology has become increasingly valuable for detecting submicroscopic chromosomal imbalances that might be missed by conventional analysis.
Indications for Cytogenetic Testing in Dermatology
Cytogenetic testing is indicated in several specific dermatological scenarios:
- Congenital genetic diseases: Patients presenting with multiple congenital anomalies, abnormal ultrasound findings, or recurrent miscarriages in the family history should be evaluated with cytogenetic testing.
- Inherited skin disorders: Genodermatoses with chromosomal basis require cytogenetic evaluation to establish diagnosis and guide management.
- Cutaneous malignancies: Chromosomal abnormalities and copy number variations account for a small percentage of skin tumors but are particularly prevalent in neoplastic conditions.
- Developmental delays and intellectual disability: Cytogenetic testing can identify chromosomal abnormalities in patients with developmental delays associated with skin findings.
- Mosaicism evaluation: Patients with features suggesting mosaicism, including segmental or linear distribution of skin lesions, may benefit from cytogenetic analysis.
- Prenatal diagnosis: After abnormal biochemical screening or ultrasound findings, cytogenetic testing of amniotic fluid can provide crucial diagnostic information.
Clinical Evaluation Before Testing
Before ordering cytogenetic testing, dermatologists should conduct a comprehensive clinical evaluation. Key red flag signs that warrant genetic investigation include:
- Erythroderma or collodion baby appearance at birth
- Blisters on sites of friction presenting at birth
- Therapy-resistant eczema with recurrent infections and growth failure
- Palmoplantar keratoderma
- Photosensitivity reactions
- Poikiloderma developing in early childhood
- Multiple benign or malignant tumors
- Cutaneous lesions in linear or segmental distribution
- Multiple hypomelanotic or hypermelanotic macules
- Loose or hanging skin (cutis laxa features)
- Positive family history of genetic skin disease
- Extra-cutaneous manifestations involving the central nervous system, skeletal system, teeth, eyes, or ears
Applications in Dermatological Conditions
Genodermatoses
Cytogenetic and related molecular diagnostic techniques are crucial for diagnosing genodermatoses. Gross chromosomal abnormalities rarely present solely with dermatological problems and often have prominent multi-system involvement, including intellectual disability. Conditions such as epidermolysis bullosa and ichthyosis have been extensively studied, with well-characterized spectra of genetic changes identified through advanced sequencing and cytogenetic methods.
Cutaneous and Systemic Malignancies
Cytogenetic testing plays an important role in diagnosing and classifying cutaneous malignancies. In cutaneous squamous cell carcinoma (cSCC), molecular diagnostic techniques have identified recurrent somatic mutations and copy number changes. Karyotyping and FISH studies in neoplastic diseases help establish diagnosis, estimate prognosis, evaluate appropriate treatment regimens, and monitor response to therapy.
Hereditary Cancer Syndromes
Genetic testing can identify variants associated with hereditary cancer syndromes with cutaneous manifestations. For example, dermatologists can refer cases to clinical genetics services for cascade testing of family members. Those identified with pathogenic variants receive skin surveillance and appropriate internal malignancy screening based on the specific genetic condition.
Advantages and Limitations
Advantages
- Detects large chromosomal abnormalities and numerical anomalies effectively
- Relatively quick turnaround time for traditional karyotyping
- Cost-effective for screening large chromosomal changes
- Established clinical protocols and interpretation guidelines
- Can detect mosaicism and structural rearrangements
- Essential for prenatal diagnosis of chromosomal abnormalities
Limitations
- Lower diagnostic yield (5-15% for karyotyping) compared to next-generation sequencing (approximately 31% diagnostic yield).
- Cannot detect point mutations or small sequence variants
- Requires dividing cells, making some tissue types difficult to analyze
- May not detect balanced chromosomal rearrangements
- Limited ability to identify single-gene disorders
- Microarray cannot reliably detect balanced translocations
Comparison with Other Genetic Testing Methods
| Testing Method | Type of Abnormality Detected | Diagnostic Yield | Key Application |
|---|---|---|---|
| Karyotyping | Numerical and large structural chromosomal abnormalities | 5-15% | Chromosomal syndromes, prenatal diagnosis |
| FISH | Specific chromosomal regions and translocations | Variable | Targeted detection of specific abnormalities |
| Chromosomal Microarray | Copy number variations and submicroscopic imbalances | 15-20% | Detection of deletions and duplications |
| Next-Generation Sequencing | Point mutations, sequence variants, structural variants | ~31% | Single-gene disorders, comprehensive genetic analysis |
Specimen Collection and Sample Handling
Proper specimen collection and handling are critical for successful cytogenetic testing. Blood samples are the most commonly used source for chromosome analysis. For prenatal diagnosis, amniotic fluid obtained through amniocentesis provides fetal cells for analysis. Skin biopsy samples can occasionally be submitted, though cultured fibroblasts or other dividing cells are preferred. Samples should be transported promptly to the laboratory under appropriate conditions to ensure cell viability for culture-dependent methods like karyotyping.
Interpretation and Clinical Reporting
Interpretation of cytogenetic results requires expertise in human genetics and understanding of the clinical context. Results are typically reported using standardized nomenclature (ISCN—International System for Human Cytogenetic Nomenclature). Dermatologists receiving cytogenetic reports should understand the significance of findings and their implications for patient management. Since 2020, dermatologists in some healthcare systems have had the ability to request certain genetic tests directly and hold responsibility for interpreting and communicating results to patients and families.
Clinical Impact and Patient Management
A confirmed cytogenetic or genetic diagnosis can significantly impact clinical management and patient outcomes. Diagnosis may provide access to specialized screening programs, such as skin cancer surveillance and internal malignancy screening for hereditary cancer syndromes. Additionally, an increasing number of targeted therapies are becoming available for genetic skin diseases, such as dystrophic epidermolysis bullosa, and opportunities to enter clinical trials for conditions like PIK3CA overgrowth spectrum.
Genomic diagnosis also enables genetic counseling for affected families. Dermatologists can counsel family members about inheritance patterns, recurrence risks, and appropriate surveillance or preventive measures. Cascade testing can identify additional affected or at-risk family members who may benefit from early intervention or screening programs.
Frequently Asked Questions
Q: What is the difference between cytogenetic testing and DNA sequencing?
A: Cytogenetic testing examines chromosomes and large-scale structural changes (such as deletions or duplications of large DNA segments), while DNA sequencing identifies small-scale variations like point mutations and specific gene sequences. Cytogenetics is particularly useful for detecting numerical chromosome abnormalities, whereas sequencing is better for identifying single-gene mutations.
Q: How long does it take to get cytogenetic test results?
A: Traditional karyotyping typically takes 7-14 days because cells must be cultured and arrested during cell division. FISH results can be available in 24-48 hours. Chromosomal microarray and other molecular methods may have different turnaround times depending on the laboratory and technique used.
Q: Can cytogenetic testing be performed on skin biopsy samples?
A: While skin biopsies can be submitted, they are less ideal for traditional karyotyping because skin cells divide slowly. Blood samples are preferred as they provide more readily dividing cells. However, cultured skin fibroblasts may be used in specialized situations.
Q: Is cytogenetic testing used for prenatal diagnosis?
A: Yes, cytogenetic testing is an important prenatal diagnostic tool. Amniotic fluid obtained through amniocentesis can be analyzed to detect chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), as well as other chromosomal imbalances.
Q: What does it mean if the karyotype is normal but clinical features suggest a genetic condition?
A: A normal karyotype does not exclude genetic disease. Many genetic conditions are caused by point mutations or small sequence changes that cannot be detected by karyotyping. In such cases, more advanced testing such as next-generation sequencing or gene-specific testing may be necessary to establish a diagnosis.
Q: How is cytogenetic testing used in cancer diagnosis?
A: In hematologic malignancies, cytogenetic testing helps diagnose leukemias and lymphomas by identifying specific chromosomal abnormalities associated with these conditions. In solid tumors including skin cancers, karyotyping and FISH studies aid in prognosis estimation, treatment selection, and monitoring response to therapy by detecting the presence or absence of abnormal clones.
References
- Genetics for dermatologists. Part 2: Clinical evaluation, sequencing technologies and interpretation — Indian Journal of Dermatology, Venereology and Leprology. 2024. https://ijdvl.com/genetics-for-dermatologists-part-2-clinical-evaluation-sequencing-technologies-and-interpretation/
- What Is Cytogenetic Testing and How Does It Work? — MyLeukemiaTeam. https://www.myleukemiateam.com/resources/what-is-cytogenetic-testing-and-how-does-it-work
- Next-generation sequencing in dermatology — Frontiers in Medicine. 2023. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1218404/full
- Genomics in Dermatology — Genomics Education, NHS. https://www.genomicseducation.hee.nhs.uk/genomics-in-healthcare/genomics-in-dermatology/
- Genetics, Cytogenetic Testing and Conventional Karyotype — National Center for Biotechnology Information (NCBI). https://www.ncbi.nlm.nih.gov/books/NBK563293/
Similar Articles
Read full bio of Sneha Tete
